| 41.32 |  +0.19 / +0.46%Today’s Change | 36.41 Today|||52-Week Range 42.20 | +8.14% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $102.2B |
Company Description
GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Employees
Shareholders
| Other institutional | 7.75% |
| Mutual fund holders | 3.77% |
| Individual stakeholders | -- |
Top Executives
| Emma Walmsley | Chief Executive Officer & Executive Director |
| Iain James Mackay | Chief Financial Officer & Executive Director |
| Jon Ellis | Vice President & Head-Science & Technology |
| Karenann K. Terrell | Chief Technology & Digital Officer |
| Hal V. Barron | Executive Director & Chief Scientific Officer |
+0.19 / +0.46%
